Effects of Pioglitazine (Actos®) or Sitagliptin (Januvia®) in Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy

被引：0
|
作者：
Handayani, Olivia
Tandra, Hans
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A182 / A182
页数：1
相关论文
共 50 条
  • [21] Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus?
    Afshin Salsali
    Richard E Pratley
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 450 - 451
  • [22] The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy
    Fouqueray, Pascale
    Pirags, Valdis
    Diamant, Michaela
    Schernthaner, Guntram
    Lebovitz, Harold E.
    Inzucchi, Silvio E.
    Bailey, Clifford J.
    DIABETES CARE, 2014, 37 (07) : 1924 - 1930
  • [23] THE COST-EFFECTIVENESS EVALUATION OF CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON METFORMIN MONOTHERAPY IN SPAIN
    Nielsen, A. T.
    Pitcher, A.
    Lovato, E.
    Schubert, A.
    Hemels, M.
    Neslusan, C.
    Gonzalez, B.
    VALUE IN HEALTH, 2015, 18 (03) : A61 - A61
  • [24] Safety and efficacy of Ertugliflozin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy in the VERTIS-Asia study
    Yang, Ming
    Ji, Linong
    Liu, Yanmei
    Miao, Heng
    Xie, Yongli
    Wang, Wei
    Mu, Yuting
    Yan, Ping
    Pan, Sharon
    Lauring, Brett
    Liu, Shu
    Huyck, Susan
    Wang, Yinna
    Terra, Steven G.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [25] Efficacy and safety of ertugliflozin in subjects with type 2 diabetes mellitus inadequately controlled on the dual combination of metformin and sitagliptin: the VERTIS SITA2 trial
    Lauring, B.
    Eldor, R.
    Liu, J.
    Dagogo-Jack, S.
    Amorin, G.
    Johnson, J.
    Hille, D.
    Huyck, S.
    Golm, G.
    Terra, S.
    Mancuso, J.
    Engel, S. S.
    DIABETOLOGIA, 2016, 59 : S93 - S93
  • [26] Randomized trial assessing the safety and efficacy of sitagliptin in Chinese patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea alone or combined with metformin
    Ba, Jianming
    Han, Ping
    Yuan, Guoyue
    Mo, Zhaohui
    Pan, Changyu
    Wu, Fan
    Xu, Lei
    Hanson, Mary E.
    Engel, Samuel S.
    Shankar, R. Ravi
    JOURNAL OF DIABETES, 2017, 9 (07) : 667 - 676
  • [27] Metformin monotherapy for adults with type 2 diabetes mellitus
    Gnesin, Filip
    Thuesen, Anne Cathrine Baun
    Kahler, Lise Katrine Aronsen
    Madsbad, Sten
    Hemmingsen, Bianca
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (06):
  • [28] Comparative Effectiveness of Sitagliptin Compared to Sulphonylureas for Type 2 Diabetes Among Elderly Patients Inadequately Controlled on Metformin
    Sharma, Manuj
    Nazareth, Irwin
    Petersen, Irene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 440 - 440
  • [29] Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin
    Al Omari, Mousa
    Khader, Yousef
    Dauod, Ali Shakir
    Yonis, Othman Ahmed Beni
    Khassawneh, Adi Harbi Mohammad
    JOURNAL OF DRUG ASSESSMENT, 2016, 5 (01) : 29 - 33
  • [30] The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy
    Tai, He
    Wang, Ming-Yue
    Zhao, Yue-Ping
    Li, Ling-Bing
    Dong, Qian-Yan
    Liu, Xin-Guang
    Kuang, Jin-Song
    MEDICINE, 2016, 95 (33)
12345